70
Views
17
CrossRef citations to date
0
Altmetric
Original Research

Diagnosis of COPD and clinical course in patients with unrecognized airflow limitation

&
Pages 199-208 | Published online: 18 Apr 2013

References

  • PauwelsRABuistASCalverleyPMJenkinsCRHurdSSGOLD Scientific CommitteeGlobal strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summaryAm J Respir Crit Care Med200116351256127611316667
  • National Institutes of Health, National Heart, Lung and Blood InstituteMorbidity and Mortality: 2012 Chartbook on Cardiovascular, Lung and Blood diseasesUS Department of Health and Human Services, Public Health Service, NIHBethesda MD http://www.nhlbi.nih.gov/resources/docs/2012_ChartBook.pdfAccessed March 13, 2013
  • ManninoDMGagnonRCPettyTLLydickEObstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1984–1994Arch Intern Med2000160111683168910847262
  • HoyertDLKochanekKDMurphySLDeath; Final Data for 1997National vital statistics reports4719Hyattsville, MDNational Center for Health Statistics1999 Available from: http://www.cdc.gov/nchs/data/nvsr/nvsr47/nvs47_19.pdfAccessed February 14, 2013
  • MurrayCJLopezADAlternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease StudyLancet19973499064149815049167458
  • MathersCDLoncarDProjections of global mortality and burden of disease from 2002 to 2030PLoS Med2006311e44217132052
  • KochanekKDXuJMurphyLSMininoAMKungHCDeaths: Preliminary Data for 2009National vital statistics reports594Hyattsville, MDNational Center for Health Statistics2011 Available from: http://www.cdc.gov/nchs/data/nvsr/nvsr59/nvsr59_04.pdfAccessed February 14, 2013
  • LundbäckBNyströmLRosenhallLStjernbergNObstructive lung disease in northern Sweden: respiratory symptoms assessed in postal surveyEur Respir J1991432572661864340
  • McDonaldMHertzRPUtilization of Veterans Affairs Medical Care Services by United States VeteransNew YorkPfizer US Pharmaceuticals2003 Available from: http://www.hawaii.edu/hivandaids/Utilization%20of%20Veterans%20Affairs%20Medical%20Care%20Services%20by%20US%20Veterans.pdfAccessed Nov 2010
  • MurphyDEChaudhryZAlmoosaKFPanosRJHigh prevalence of chronic obstructive pulmonary disease among veterans in the urban midwestMil Med2011176555256021634301
  • RennardSDecramerMCalverleyPMImpact of COPD in North America and Europe in 2000: subjects’ perspective of Confronting COPD International SurveyEur Respir J200220479980512412667
  • TakahashiTIchinoseMInoueHShiratoKHattoriTTakishimaTUnderdiagnosis and undertreatment of COPD in primary care settingsRespirology20038450450814629656
  • DamarlaMCelliBRMullerovaHXPinto-PlataVMDiscrepancy in the use of confirmatory tests in patients hospitalized with the diagnosis of chronic obstructive pulmonary disease or congestive heart failureRespir Care200651101120112417005056
  • FukuchiYNishimuraMIchinoseMCOPD in Japan: The Nippon COPD Epidemiology studyRespirology20049445846515612956
  • Ackermann-LiebrichUKuna-DibbertBProbst-HenschNMSAPALDIA TeamFollow-up of the Swiss Cohort Study on Air Pollution and Lung Diseases in Adults (SAPALDIA 2) 1991–2003: methods and characterization of participantsSoz Praventivmed200550424526316167509
  • de MarcoRAccordiniSAntòJMLong-term outcomes in mild/moderate chronic obstructive pulmonary disease in the European community respiratory health surveyAm J Respir Crit Care Med20091801095696319696441
  • BurgelPRNesme-MeyerPChanezPInitiatives Bronchopneumopathie Chronique Obstructive Scientific CommitteeCough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjectsChest2009135497598219017866
  • BhowmikASeemungalTASapsfordRJWedzichaJARelation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbationsThorax200055211412010639527
  • ManninoDMDiaz-GuzmanEInterpreting lung function data using 80% predicted and fixed thresholds identifies patients at increased risk of mortalityChest20121411738021659434
  • Ekberg-AronssonMPehrssonKNilssonJANilssonPMLöfdahlCGMortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitisRespir Res200569816120227
  • American Thoracic Society Standardization of spirometryAJRRCM199515211071136
  • HankinsonJLOdencrantzJRFedanKBSpirometric Reference Values from a Sample of the General U.S. PopulationAm J of Respir and Crit Care Med19991591791879872837
  • Global Initiative for Chronic Obstructive Lung Disease [homepage on the Internet] Available from: http://www.goldcopd.orgAccessed February 14, 2013
  • GraphPad SoftwareQuick Calcs [webpage on the Internet]La Jolla, CAGraphPad Software, Inc. Available from: http://graphpad.com/quickcalcs/Accessed August 1, 2012
  • BuistASVollmerWMSullivanSDThe Burden of Obstructive Lung Disease Initiative (BOLD): rationale and designCOPD20052227728317136954
  • MenezesAMPerez-PadillaRHallalPCPLATINO TeamWorldwide burden of COPD in high- and low-income countries. Part II. Burden of chronic obstructive lung disease in Latin America: the PLATINO studyInt J Tuberc Lung Dis200812770971218544192
  • SchirnhoferLLamprechtBFirleiNUsing targeted spirometry to reduce non-diagnosed chronic obstructive pulmonary diseaseRespiration201181647648220720402
  • DrummondMBHanselNNConnettJEScanlonPDTashkinDPWiseRASpirometric predictors of lung function decline and mortality in early chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2012185121301130622561963
  • DecramerMCelliBKestenSLystigTMehraSTashkinDPUPLIFT investigatorsEffect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomized controlled trialLancet200937496961171117819716598
  • JenkinsCRJonesPWCalverleyPMEfficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH studyRespir Res2009105919566934
  • FreemanDLeeAPriceDEfficacy and safety of tiotropium in COPD patients in primary care – the SPiRiva Usual CarE (SPRUCE) studyRespir Res200784517605774
  • AnthonisenNRSmoking, lung function, and mortalityThorax200055972973010950888
  • PelkonenMTukiainenHTervahautaMPulmonary function, smoking cessation and 30 year mortality in middle aged Finnish menThorax200055974675010950892
  • PriceaDFreemanaDClelandJKaplanACerasoliFEarlier diagnosis and earlier treatment of COPD in primary carePrim Care Respir J2011201152220871945
  • MapelDWRobinsonSBDastaniHBShahHPhillipsALLydickEThe direct medical costs of undiagnosed chronic obstructive pulmonary diseaseValue Health200811462863618194402
  • AkazawaMHalpernRRiedelAAStanfordRHDalalABlanchetteCMEconomic burden prior to COPD diagnosis: a matched case-control study in the United StatesRespir Med2008102121744175218760581
  • JanssonSALindbergAEricssonACost differences for COPD with and without physician-diagnosisCOPD20052442743417147008
  • MartinezFJRaczekAESeiferFDCOPD-PS Clinician Working GroupDevelopment and initial validation of a self-scored COPD Population Screener Questionnaire (COPD-PS)COPD200852859518415807
  • CalverleyPMNordykeRJHalbertRJIsonakaSNonikovDDevelopment of a population-based screening questionnaire for COPDCOPD20052222523217136949
  • BaileyWCSciurbaFCHananiaNADevelopment and validation of the Chronic Obstructive Pulmonary Disease Assessment Questionnaire (COPD-AQ)Prim Care Respir J200918319820719492178
  • García-RioFSorianoJBMiravitllesMOverdiagnosing subjects with COPD using the 0.7 fixed ratio: correlation with a poor health-related quality of lifeChest201113951072108021183609
  • LedererDJEnrightPLKawutSMCigarette smoking associated with subclinical parenchymal lung disease: the Multi-Ethnic Study of Athersclerosis (MESA)-Lung StudyAm J Respir Crit Care Med2009180540741419542480
  • HurstJRDonaldsonGCQuintJKGoldringJJBaghai-RavaryRWedzichaJATemporal clustering of exacerbations in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2009179536937419074596
  • CasanovaCde TorresJPAguirre-JaímeAThe progression of Chronic Obstructive Pulmonary Disease is Heterogeneous: The experience of the BODE cohortAm J Respir Crit Care Med201118491015102121836135
  • Brito-MutunayagamRAppletonSLWilsonDHRuffinREAdamsRJNorth West Adelaide Cohort Health Study TeamGlobal initiative for Chronic Obstructive Lung Disease Stage 0 is associated with excess FEV(1) decline in a representative population sampleChest2010138360561320418365
  • WaltersJAWaltersEHNelsonMFactors associated with misdiagnosis of COPD in primary carePrim Care Respir J201120439640221687918